Skip to main content
COO
NASDAQ Life Sciences

CooperCompanies Q1 Adjusted EPS Beats Estimates, Driven by Improved Margins

feedReported by Reuters
Sentiment info
Positive
Importance info
8
Price
$84.695
Mkt Cap
$15.717B
52W Low
$61.775
52W High
$91.6
Market data snapshot near publication time

summarizeSummary

CooperCompanies reported Q1 adjusted EPS of $1.10, surpassing analyst estimates of $1.03, primarily driven by improved operating margins and strong performance in its premium MyDay portfolio. While Q1 revenue slightly missed expectations at $1.02 billion against a $1.03 billion consensus, the EPS beat and margin expansion are positive indicators. The company also issued fiscal 2026 guidance, projecting revenue of $4.306-$4.346 billion and non-GAAP EPS of $4.58-$4.66. During the quarter, CooperCompanies repurchased $92.5 million of common stock, aligning with its capital allocation strategy, which saw a significant $1 billion expansion to its share repurchase program announced in a DEF 14A filing on February 24, 2026. The EPS beat and forward guidance are material for traders, who will now focus on the company's ability to execute on its full-year projections and maintain margin strength.

At the time of this announcement, COO was trading at $84.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.7B. The 52-week trading range was $61.78 to $91.60. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed COO - Latest Insights

COO
Mar 06, 2026, 4:12 PM EST
Filing Type: 10-Q
Importance Score:
8
COO
Mar 05, 2026, 4:38 PM EST
Source: Reuters
Importance Score:
8
COO
Mar 05, 2026, 4:27 PM EST
Filing Type: 8-K
Importance Score:
8
COO
Feb 24, 2026, 4:19 PM EST
Filing Type: DEF 14A
Importance Score:
8
COO
Feb 03, 2026, 9:58 PM EST
Filing Type: 8-K
Importance Score:
8